首页> 美国卫生研究院文献>Journal of Clinical Oncology >Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910

【2h】

Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910

机译：局部前列腺癌放疗前雄激素抑制的持续时间：放射治疗肿瘤学小组随机临床试验9910

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo determine whether prolonged androgen suppression (AS) duration before radiotherapy improves survival and disease control in prostate cancer.

机译：目的确定放疗前延长雄激素抑制（AS）时间是否可改善前列腺癌的生存率和疾病控制。

著录项

期刊名称 Journal of Clinical Oncology
作者
Thomas M. Pisansky; Daniel Hunt; Leonard G. Gomella; Mahul B. Amin; Alexander G. Balogh; Daniel M. Chinn; Michael J. Seider; Marie Duclos; Seth A. Rosenthal; Glenn S. Bauman; Elizabeth M. Gore; Marvin Z. Rotman; Himanshu R. Lukka; William U. Shipley; James J. Dignam; Howard M. Sandler;
展开▼
作者单位

展开▼
年(卷),期 -1(33),4
年度 -1
页码 332–339
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Duration of Androgen Suppression before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910 Editorial Comment [J] . Taneja Samir S. The Journal of Urology . 2016,第1期

机译：回复：局部前列腺癌放疗前雄激素抑制的持续时间：放射治疗肿瘤学小组随机临床试验9910社论评论
2. Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910 [J] . Pisansky Thomas M., Hunt Daniel, Gomella Leonard G., Journal of Clinical Oncology . 2015,第4期

机译：局部前列腺癌放疗前雄激素抑制的持续时间：放射治疗肿瘤学小组随机临床试验9910
3. Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials [J] . Hallemeier Christopher L., Zhang Peixin, Pisansky Thomas M., International Journal of Radiation Oncology, Biology, Physics . 2019,第5期

机译：前列腺癌前列腺癌前列腺抑制后前列腺癌患者接受短期雄激素抑制和外梁辐射治疗：4个NRG肿瘤治疗肿瘤学系的汇总分析随机临床试验
4. An Update on the Bladder Cancer Clinical Trials of the Radiation Therapy Oncology Group [C] . Douglas M. Dahl, William U. Shipley Genitourinary Cancers Symposium . 2013

机译：放射治疗肿瘤组膀胱癌临床试验的更新
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. A Phase III trial of 2 Years of Androgen Suppression (AS) and Radiation Therapy (RT) with or without Adjuvant Chemotherapy (CT) for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group (RTOG) Phase III Randomized Trial NRG Oncology RTOG 9902 [O] . Seth A. Rosenthal, Daniel Hunt, A. Oliver Sartor, -1

机译：高危前列腺癌有或没有辅助化疗（CT）的2年雄激素抑制（AS）和放射治疗（RT）的III期试验：放射疗法肿瘤学组（RTOG）的最终结果III期随机试验NRG肿瘤学RTOG 9902
7. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. [O] . Rosenthal Seth A., Hunt Daniel, Sartor A. Oliver, 2015

机译：2年雄激素抑制和放射治疗的3期试验，有或没有辅助化疗治疗高风险前列腺癌：放射治疗的最终结果肿瘤组第3阶段随机试验NRG肿瘤学RTOG 9902。

Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910

摘要

著录项

相似文献

相关主题

期刊订阅